Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For 2022, Dhillon told investors that the company is preparing to make significant headway with the clinical development of SBI-100, the...
We are a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant...
We are a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant...
Skye Bioscience inc (OTCQB:SKYE)'s (OTCQB:SKYE) Punit Dhillon talks to Proactive London about the company's cannabinoid-derived molecules to...
Skye Bioscience inc (OTCQB:SKYE)'s (OTCQB:SKYE) Punit Dhillon talks to Proactive London about the company's cannabinoid-derived molecules to...